Stemtech (STEK) Share-based Compensation (2021 - 2025)
Stemtech's (STEK) quarterly Share-based Compensation came in at -$260816.0 in Q4 2025, down 224.76% year-on-year from $209060.0 in Q4 2024, and down 154.09% quarter-over-quarter from $482148.0 in Q3 2025.
Stemtech (STEK) Share-based Compensation (2021 - 2025) Analysis & Trends
Stemtech has disclosed Share-based Compensation across 5 years of filings, most recently posting -$260816.0 for Q4 2025.
- Share-based Compensation for Q4 2025 came in at -$260816.0, down 224.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $439054.0 (changed 0.27% YoY), and the FY2025 annual result was $439054.0, changed 0.27% from the prior year.
- Share-based Compensation came in at -$260816.0 for Q4 2025 at Stemtech, down from $482148.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $482148.0 in Q3 2025 to a low of -$367004.0 in Q3 2021.
- The 5-year median for Share-based Compensation is $110665.0 (2022), against an average of $132622.6.
- Across the five-year window, Share-based Compensation slumped 422.69% in 2024 and soared 235.01% in 2025, its largest moves.
- Stemtech's Share-based Compensation stood at $439054.0 in 2021, then retreated by 0.0% to $439053.0 in 2022, then plunged by 75.94% to $105637.0 in 2023, then soared by 97.9% to $209060.0 in 2024, then plunged by 224.76% to -$260816.0 in 2025.
- The last three Share-based Compensation figures came in at -$260816.0 (Q4 2025), $482148.0 (Q3 2025), and $109462.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Stemtech | - | - | 354,677.00 | -260,816.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -260,816.00 |
| Dec 31, 2025 | -260,816.00 |
| Sep 30, 2025 | 482,148.00 |
| Sep 30, 2025 | 482,148.00 |
| Jun 30, 2025 | 109,462.00 |
| Jun 30, 2025 | 109,462.00 |
| Mar 31, 2025 | 108,260.00 |
| Mar 31, 2025 | 108,260.00 |
| Dec 31, 2024 | 209,060.00 |
| Dec 31, 2024 | 209,060.00 |
| Sep 30, 2024 | -357,110.00 |
| Sep 30, 2024 | -357,110.00 |
| Jun 30, 2024 | 478,843.00 |
| Jun 30, 2024 | 478,843.00 |
| Mar 31, 2024 | 109,463.00 |
| Mar 31, 2024 | 109,463.00 |
| Dec 31, 2023 | 105,637.00 |
| Dec 31, 2023 | 105,637.00 |
| Sep 30, 2023 | 110,665.00 |
| Sep 30, 2023 | 110,665.00 |